Form 13-F position report

DISC MEDICINE INC

Reported by Foresite Capital Management V LLC

IRON CUSIP 254604101 Manager CIK 0001792206

Reported 374,069 shares, unchanged from the prior quarter.

Reported value -10.5%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 8.47% This manager · Q3 2026
Shares 374,069 Quarter-end amount reported
Reported value $24,486,557 Fair value at quarter end
Consecutive quarters held 16 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-12-31 4843454
2023-03-31 5160040
2023-06-30 10811977
2023-09-30 11440241
2023-12-31 14065311
2024-03-31 15161119
2024-06-30 13479040
2024-09-30 14696251
2024-12-31 18960975
2025-03-31 14845785
2025-06-30 15838694
2025-09-30 19762480
2025-12-31 23749069
2026-03-31 23917972
2026-06-30 27359407
2026-09-30 24486557

Quarterly position history

How this manager's reported quarter-end position changed over time.

16 quarters
Quarterly reported position history for DISC MEDICINE INC held by Foresite Capital Management V LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Unchanged 374,069 0 (0.0%) 8.47% $24,486,557 2026-11-16
Q2 2026 Unchanged 374,069 0 (0.0%) 7.55% $27,359,407 2026-08-14
Q1 2026 Added 374,069 +75,000 (25.1%) 8.83% $23,917,972 2026-05-15
Q4 2025 Unchanged 299,069 0 (0.0%) 14.45% $23,749,069 2026-02-17
Q3 2025 Unchanged 299,069 0 (0.0%) 18.17% $19,762,480 2025-11-14
Q2 2025 Unchanged 299,069 0 (0.0%) 19.62% $15,838,694 2025-08-12
Q1 2025 Unchanged 299,069 0 (0.0%) 16.94% $14,845,785 2025-05-15
Q4 2024 Unchanged 299,069 0 (0.0%) 15.78% $18,960,975 2025-02-14
Q3 2024 Unchanged 299,069 0 (0.0%) 10.21% $14,696,251 2024-11-14
Q2 2024 Added 299,069 +55,556 (22.8%) 8.61% $13,479,040 2024-08-13
Q1 2024 Unchanged 243,513 0 (0.0%) 14.23% $15,161,119 2024-05-15
Q4 2023 Unchanged 243,513 0 (0.0%) 19.16% $14,065,311 2024-02-13
Q3 2023 Unchanged 243,513 0 (0.0%) 18.25% $11,440,241 2023-11-13
Q2 2023 Unchanged 243,513 0 (0.0%) 7.9% $10,811,977 2023-08-11
Q1 2023 Unchanged 243,513 0 (0.0%) 3.81% $5,160,040 2023-05-12
Q4 2022 New 243,513 +243,513 (0.0%) 3.76% $4,843,454 2023-02-13

Who else reported the position

259 managers reported DISC MEDICINE INC for Q3 2026.

Managers reporting DISC MEDICINE INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Reduced 4,803,145 -91,328 0.01% $314,413,870 16 qtrs
BlackRock Inc Added 2,532,863 +64,964 < 0.01% $165,801,211 9 qtrs
RA CAPITAL MANAGEMENT L P Unchanged 2,450,221 0 1.61% $160,391,467 7 qtrs
JPMorgan Chase & Co Reduced 1,812,170 -63,625 < 0.01% $119,497,054 16 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 1,756,490 +15,139 0.02% $114,979,835 14 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 1,655,238 -220,161 0.01% $108,353,000 14 qtrs
Vestal Point Capital LP Added 1,635,000 +85,000 2.77% $107,027,100 6 qtrs
STATE STREET CORPORATION Reduced 1,405,446 -243,390 < 0.01% $92,000,495 16 qtrs
Atlas Venture Life Science Advisors LLC Reduced 1,384,025 -129,850 14.35% $90,598,277 16 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 1,384,014 +14,987 < 0.01% $90,597,556 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
374,069
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.